4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid

C23H30ClN5O6 — CID 175325032

IUPAC4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid
SMILESO=C1CCN(c2cc(OCC(=O)N3CCC(CN4CCN(C(=O)O)CC4)CC3)ccc2Cl)C(=O)N1
InChIInChI=1S/C23H30ClN5O6/c24-18-2-1-17(13-19(18)29-8-5-20(30)25-22(29)32)35-15-21(31)27-6-3-16(4-7-27)14-26-9-11-28(12-10-26)23(33)34/h1-2,13,16H,3-12,14-15H2,(H,33,34)(H,25,30,32)
InChIKeyVBLZJWLSMVZCIT-UHFFFAOYSA-N
MW507.98 g/mol
LogP1.70
Rot. Bonds6

About 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid

4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid (PubChem CID 175325032) has the molecular formula C23H30ClN5O6 and a molecular weight of 507.98 g/mol. Its IUPAC name is 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid.

Molecular Properties

Compound Name4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid
PubChem CID175325032
Molecular FormulaC23H30ClN5O6
Molecular Weight507.98 g/mol
Exact Mass507.19
IUPAC Name4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid
SMILESO=C1CCN(c2cc(OCC(=O)N3CCC(CN4CCN(C(=O)O)CC4)CC3)ccc2Cl)C(=O)N1
InChIInChI=1S/C23H30ClN5O6/c24-18-2-1-17(13-19(18)29-8-5-20(30)25-22(29)32)35-15-21(31)27-6-3-16(4-7-27)14-26-9-11-28(12-10-26)23(33)34/h1-2,13,16H,3-12,14-15H2,(H,33,34)(H,25,30,32)
InChIKeyVBLZJWLSMVZCIT-UHFFFAOYSA-N
XLogP1.70
TPSA122.73 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500507.98
LogP ≤ 51.70
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid?
The IUPAC name of 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid (CID 175325032) is 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid.
What is the SMILES notation for 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid?
The canonical SMILES for 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid is O=C1CCN(c2cc(OCC(=O)N3CCC(CN4CCN(C(=O)O)CC4)CC3)ccc2Cl)C(=O)N1.
What is the InChIKey of 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid?
The InChIKey is VBLZJWLSMVZCIT-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H30ClN5O6/c24-18-2-1-17(13-19(18)29-8-5-20(30)25-22(29)32)35-15-21(31)27-6-3-16(4-7-27)14-26-9-11-28(12-10-26)23(33)34/h1-2,13,16H,3-12,14-15H2,(H,33,34)(H,25,30,32).
What are the key properties of 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid?
4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid has a molecular weight of 507.98 g/mol, XLogP of 1.70, 6 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[1-[2-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)phenoxy]acetyl]piperidin-4-yl]methyl]piperazine-1-carboxylic acid is sourced from PubChem (CID 175325032), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).